Overview
InMode Q3 2025 revenue of $93.2 mln beats analyst expectations
Net income for Q3 2025 misses analyst estimates
Outlook
InMode maintains full-year 2025 revenue guidance between $365 mln and $375 mln
Non-GAAP EPS for 2025 expected between $1.55 and $1.59
Company continues to monitor geopolitical developments in Israel
Result Drivers
REVENUE DECLINE - Q3 revenue decreased due to absence of pre-order sales from previous year
CONSUMABLES GROWTH - Revenue from consumables and services increased by 26% year-over-year
U.S. SALES IMPACT - Lower U.S. sales affected operating margins, the company's most profitable region
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q3 Revenue | Beat | $93.17 mln | $88.34 mln (7 Analysts) |
Q3 Net Income | Miss | $21.86 mln | $22.67 mln (5 Analysts) |
Q3 Gross Margin | 78% | ||
Q3 Pretax Profit | Beat | $25.61 mln | $24.98 mln (6 Analysts) |
Q3 Operating Expenses | $51.41 mln |
Analyst Coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy", 6 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the advanced medical equipment & technology peer group is "buy."
Wall Street's median 12-month price target for Inmode Ltd is $16.00, about 8.6% above its November 4 closing price of $14.63
The stock recently traded at 9 times the next 12-month earnings vs. a P/E of 8 three months ago
Press Release: ID:nPn6WqHSJa
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Comments